https://www.livemint.com/companies/sun-pharma-alopecia-drug-leqselvi-us-patent-dispute-pharmaceutical-market-deuruxolitinib-clinical-trials-11752504343463.html
Sun recieved approval from the US Food and Drug Administration for Leqselvi in July 2024. Soon after the regulator's approval, Incyte Corporation filed a...
sun pharmalaunchesalopeciadrugleqselvi